The mutant frequencies and types of mutations induced by Comfrey in the lungs of transgenic big blue rats

Journal of Food and Drug Analysis

Volumn 15, Issue 4, 2007, Pages 458-465

  Mei, Xunbai ^a   Chen, Tao ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Comfrey; Mutation; Pyrrolizidine alkaloids; Tandem substitution

Indexed keywords

ALANINE; COMFREY EXTRACT; CYSTEINE; GLYCINE; PYRROLIZIDINE ALKALOID; THREONINE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; GENE MUTATION; GENOTOXICITY; LUNG TOXICITY; MALE; MUTAGENICITY; MUTANT; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; RAT; TANDEM REPEAT; TRANSGENIC RAT;

RATTUS; SYMPHYTUM; SYMPHYTUM OFFICINALE;

EID: 40749113182     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Buche, J. 2004. Comfrey - (Symphytum Officinale). http://seasilver.threadnet.com/Preventorium/comfrey.htm.
2. Hirono, I., Mori, H. and Haga, M. 1978. Carcinogenic activity of Symphytum Officinale. J. Natl. Cancer Inst. 61: 865-869.
3. Buchman, D. D. 1979. Herbal Medicine. pp. 3-8. New York, Gramercy Publishing Company.
4. Rode, D. 2002. Comfrey toxicity revisited. Trends Pharmacol. Sci. 23: 497-499.
5. Ridker, P. M., Ohkuma, S., McDermott, W. V., Trey, C. and Huxtable, R. J. 1985. Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 88: 1050-1054.
6. Yeong, M. L., Swinburn, B., Kennedy, M. and Nicholson, G. 1990. Hepatic veno-occlusive disease associated with comfrey ingestion. J. Gastroenterol. Hepatol. 5: 211-214.
7. White, R. D., Krumperman, P. H., Cheeke, P. R. and Buhler, D. R. 1983. An evaluation of acetone extracts from six plants in the Ames mutagenicity test. Toxicol. Lett. 15: 25-31.
8. Mei, N., Guo, L., Fu, P. P., Heflich, R. H. and Chen, T. 2005. Mutagenicity of comfrey (Symphytum Officinale) in rat liver. Br. J. Cancer 92: 873-875.
9. Snider, S. 1991. Beware the unknown brew. Herbal teas and toxicity. FDA Consumer 25: 30-33.
10. Stengl, P., Wiedenfeld, H. and Roeder, E. 1982. Hepatotoxic pyrrolizidine alkaloids in symphytum preparations. Dtsch. Apoth.-Ztg. 122: 851-855.
11. Vollmer, J., Steiner, N., Larsen, G., Muirhead, K. and Molyneux, R. 1987. Pryrrolizidine alkaloids: Testing for toxic constituents of comfrey. J. Chem. Educ. 64: 1027-1030.
12. Couet, C. E., Crews, C. and Hanley, A. B. 1996. Analysis, separation, and bioassay of pyrrolizidine alkaloids from comfrey (Symphytum Officinale). Nat. Toxins 4: 163-167.
13. Betz, J. M., Eppley, R. M., Taylor, W. C. and Andrzejewski, D. 1994. Determination of pyrrolizidine alkaloids in commercial comfrey products (Symphytum sp). J. Pharm. Sci. 83: 649-653.
14. Stickel, F. and Seitz, H. K. 2000. The efficacy and safety of comfrey. Public Health Nutr. 3: 501-508.
15. FDA. 2001. FDA advises dietary supplement manufacturers to remove coniftey products from the market. (http://www.cfsan.fda.gov/~dms/ dspltr06.html)
16. Kohler, S. W., Provost, G. S., Fieck, A., Kretz, P. L., Bullock, W. O., Putman, D. L., Sorge, J. A. and Short, J. M. 1991. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/ lacI shuttle vector. Environ. Mol. Mutagen 18: 316-321.
17. Kohler, S. W., Provost, G. S., Fieck, A., Kretz, P. L., Bullock, W. O., Sorge, J. A., Putman, D. L. and Short, J. M. 1991. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. U S A 88: 7958-7962.
18. Provost, G. S., Kretz, P. L., Hamner, R. T., Matthews, C. D., Rogers, B. J., Lundberg, K. S., Dycaico, M. J. and Short, J. M. 1993. Transgenic systems for in vivo mutation analysis [see comments]. Mutat. Res. 288: 133-149.
19. Kohler, S. W., Provost, G. S., Kretz, P. L., Fieck, A., Sorge, J. A. and Short, J. M. 1990. The use of transgenic mice for short-term, in vivo mutagenicity testing. Genet. Anal. Tech. Appl. 7: 212-218.
20. Slikker, W., Mei, N. and Chen, T. 2004. N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults. Toxicol. Sci. 81: 112-120.
21. Chen, T., Gamboa da Costa, G., Marques, M. M., Shelton, S. D., Beland, F. A. and Manjanatha, M. G. 2002. Mutations induced by alpha-hydroxytamoxifen in the lacI and cII genes of Big Blue transgenic rats. Carcinogenesis 23: 1751-1757.
22. Cariello, N. F. 1994. Database and software for the analysis of mutations at the human hprt gene. Nucleic Acids Res. 22: 3547-3548.
23. Adams, W. T. and Skopek, T. R. 1987. Statistical test for the comparison of samples from mutational spectra. J. Mol. Biol. 194: 391-396.
24. Chou, M. W., Wang, Y. P., Yan, J., Yang, Y. C., Beger, R. D., Williams, L. D., Doerge, D. R. and Fu, P. P. 2003. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Toxicol. Lett. 145: 239-247.
25. Chou, M. W., Jian, Y., Williams, L. D., Xia, Q., Churchwell, M., Doerge, D. R., and Fu, P. P. 2003. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid. Chem. Res. Toxicol. 16: 1130-1137.
26. Wang, Y. P., Fu, P. P. and Chou, M. W. 2005. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo. Int. J. Environ. Res. Public Health 2: 74-79.
27. Kay, J. M., Heath, D., Smith, P., Bras, G. and Summerell, J. 1971. Hypertensive pulmonary vascular disease produced in rats by administration of the pyrrolizidine alkaloid fulvine. J. Pathol. 103: P3.
28. Molteni, A., Ward, W. F., Ts'ao, C. H. and Hinz, J. M. 1989. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026. Biochem. Pharmacol. 38: 2411-2419.
29. Molteni, A., Ward, W. F., Ts'ao, C. H. and Solliday, N. H. 1989. Monocrotaline pneumotoxicity in mice. Virchows Arch B Cell Pathol. Incl. Mol. Pathol. 57: 149-155.
30. Yan, C. C. and Huxtable, R. J. 1995. The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat. Toxicon 33: 627-634.
31. Yan, C. C. and Huxtable, R. J. 1996. Effects of monocrotaline, a pyrrolizidine alkaloid, on glutathione metabolism in the rat. Biochem. Pharmacol. 51: 375-379.
32. Hirono, I., Mori, H., Yamada, K., Hirata, Y. and Haga, M. 1977. Carcinogenic activity of petasitenine, a new pyrrolizidine alkaloid isolated from Petasites japonicus Maxim. J. Natl. Cancer Inst. 58: 1155-1157.
33. Hirono, I., Mori, H. and Culvenor, C. C. 1976. Carcinogenic activity of coltsfoot, Tussilago farfara 1. Gann 67: 125-129.
34. Schoental, R. 1968. Toxicology and carcinogenic action of pyrrolizidine alkaloids. Cancer Res. 28: 2237-2246.
35. Mei, N., Guo, L., Zhang, L., Shi, L., Sun, Y. A., Fung, C., Moland, C. L., Dial, S. L., Fuscoe, J. C. and Chen, T. 2006. Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum Officinale). BMC Bioinformatics 7: S12-16.
36. Schaneberg, B. T., Molyneux, R. J. and Khan, I. A. 2004. Evaporative light scattering detection of pyrrolizidine alkaloids. Phytochem. Anal. 15: 36-39.
37. Kim, N. C., Oberlies, N. H., Brine, D. R., Handy, R. W., Wani, M. C. and Wall, M. E. 2001. Isolation of symlandine from the roots of common comfrey (Symphytum Officinale) using countercurrent chromatography. J. Nat. Prod. 64: 251-253.
38. Hirono, I., Haga, M., Fujii, M., Matsuura, S., Matsubara, N., Nakayama, M., Furuya, T., Hikichi, M., Takanashi, H. and Uchida, E. 1979. Induction of hepatic tumors in rats by senkirkine and symphytine. J. Natl. Cancer Inst. 63: 469-472.
39. Svoboda, D. J. and Reddy, J. K. 1974. Laslocarpine-induced, transplantable squamous cell carcinoma of rat skin. J. Natl. Cancer Inst. 53: 1415-1418.
40. Mei, N., Heflich, R. H., Chou, M. W. and Chen, T. 2004. Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic big blue rats. Chem. Res. Toxicol. 17: 814-818.
41. Fu, P. P., Xia, Q., Lin, G. and Chou, M. W. 2004. Pyrrolizidine alkaloids--genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab. Rev. 36: 1-55.
42. Rao, M. S. and Reddy, J. K. 1978. Malignant neoplasms in rats fed lasiocarpine. Br. J. Cancer 37: 289-293.
43. Mattocks, A. R. and Cabral, J. R. 1982. Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues. Cancer Lett. 17: 61-66.